Vital Health Podcast
Health & Wellness Podcasts
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.
Location:
United States
Description:
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stakeholders.
Twitter:
@VitalTransform
Language:
English
Kim Hawkins - Project Co-Lead of IMI’s Trials@Home
Duración:00:32:51
Douglas Holtz-Eakin, “Indications are going to be deeply affected by the IRA”
Duración:00:54:59
John LaMattina – Drug Price Controls and IP Attacks Get Real
Duración:00:32:43
Kate Hudson & Joseph P. Allen – The Fact Free Attacks on IP
Duración:00:35:41
VT’s Grumpy Old Men – The Administration’s Threats to use March-In Rights
Duración:00:53:48
PRIME-ROSE: The EU’s DRUP Trial Champion
Duración:00:25:44
Peter Kolchinsky - "IRA's 9 Years Is Too Short"
Duración:00:56:37
Christian Schneider, CMO Biopharma Excellence
Duración:00:49:05
Bettina Ryll at the 2023 ESMO Conference
Duración:00:40:37
Dan Leonard, Executive Director, We Work For Health
Duración:00:36:18
Cancer Drug Developer Dr. Steve Potts' Congressional Testimony on the IRA
Duración:00:41:06
Amy Miller and the PhRMA Foundation Push the R&D Envelope
Duración:00:38:15
VT’s Grumpy Old Men on Price Controls and IP Attacks
Duración:00:54:23
Taking the Helm Mid Drug Pricing Maelstrom
Duración:00:32:14
Best-of Edition: Looking back on the COVID-19 outbreak part 2
Duración:00:39:22
Best-of Edition: Looking back on the COVID-19 outbreak
Duración:00:47:30
CMS' Restrictions on Alzheimer's Drugs
Duración:00:40:53
Biocom California Grapples with Regulatory Assaults on all Fronts
Duración:00:42:54
Amitabh Chandra - IRA’s potential impact on the US biopharma ecosystem
Duración:00:39:23
NJ’s Biopharma Sector in a Price Controlled World
Duración:00:17:24